Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News AdvisorShares Psychedelics ETF PSIL

The AdvisorShares Psychedelics ETF (the Fund) seeks long-term capital appreciation. The Fund is an actively managed exchange-traded fund (ETF) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in (i) securities of companies that derive at least 50% of their net revenue from or... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (ARCA:PSIL)

AdvisorShares Announces Reverse Split of ETF

PR Newswire August 30, 2024

AdvisorShares Expands Cannabis ETF Offerings, Launches MSOS 2x Daily ETF (Ticker: MSOX)

PR Newswire August 24, 2022

Wesana Health Announces Inclusion in the AdvisorShares Psychedelics ETF

GlobeNewswire October 1, 2021

Mindset Pharma Announces Inclusion in NYSE Listed AdvisorShares Psychedelics Exchange Traded Fund (ETF)

GlobeNewswire September 23, 2021

Revive Therapeutics Included in AdvisorShares® Newly Launched Psychedelics ETF

GlobeNewswire September 21, 2021

Small Pharma Included in AdvisorShares® Newly Launched Psychedelics ETF

GlobeNewswire September 20, 2021
View More News ››

Opinion & Analysis (ARCA:PSIL)

No current opinion is available.
View More Opinion ››

Bullboard Posts (ARCA:PSIL)

$ORIG Provides Exposure To The Private Psychedelic Industry

After the recent move by the Canadian govt. allowing physicians to prescribe psychedelic therapies, watch for Origin Therapeutics to go...
partystocker - February 20, 2022

$ORIG news

Origin Therapeutics has released their official leadership team. Looks like a lot of experienced individuals in the psychedelics and...
partystocker - November 21, 2021

Psychedelic Sector Momentum Shift Near?

<< View Post To Watch Video >>
Stockchartswim - October 31, 2021
View more Bullboard ››

Innocan Pharma Corp

Innocan Pharma Corp

Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the ...
View More »